FLAIR

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

Retrieved on: 
Monday, October 9, 2023
Neurology, Software, Health, FDA, Artificial Intelligence, Medical Devices, Health Technology, Technology, Deep learning, DWI, Patient, FLAIR, Brain, Hyperfine structure, Medical imaging

Built on a robust AI foundation, the latest software brings image quality enhancements to the Swoop® system’s diffusion-weighted imaging (DWI) sequence.

Key Points: 
  • Built on a robust AI foundation, the latest software brings image quality enhancements to the Swoop® system’s diffusion-weighted imaging (DWI) sequence.
  • With this latest software update, Hyperfine, Inc. expands the Swoop® system’s AI denoising capabilities by incorporating advanced image post-processing into the DWI sequence.
  • Denoising enables a crisper image that potentially helps clinicians more accurately diagnose, treat, and monitor patients undergoing brain imaging.
  • More than milestones, it's about reshaping patient care, empowering clinicians, and advancing brain imaging.”
    Hyperfine, Inc. will roll out the updated Swoop® system software in the coming months.

Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging

Retrieved on: 
Tuesday, February 28, 2023
Diagnosis, DWI, Hyperfine structure, Software, Acquisition, SNR, FDA, MRI, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Health, American Heart Association, FLAIR, Stroke, Food, Signal-to-noise ratio, Medical imaging

This updated software, which significantly improves diffusion-weighted imaging (DWI), highlights the company’s commitment to continuously improving image quality.

Key Points: 
  • This updated software, which significantly improves diffusion-weighted imaging (DWI), highlights the company’s commitment to continuously improving image quality.
  • In this clearance, Hyperfine, Inc. achieved a significant 42% increase in the signal-to-noise ratio (SNR) for the DWI sequence compared to the previous software version.
  • The American Stroke Association guidelines recommend brain imaging be conducted 24 to 36 hours after ischemic stroke treatmenti.
  • For more information about the Swoop® Portable MR Imaging® System, please visit hyperfine.io .

Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System

Retrieved on: 
Monday, February 13, 2023
Signal-to-noise ratio, Brain, Hospital, DWI, FLAIR, MRI, Patient, Software, Food, Pathology, FDA, Magnetic resonance imaging, Growth, Hyperfine structure, Diffusion, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, AI, Medical device, Medical imaging

The most recently cleared Swoop® software improves the image quality of the diffusion-weighting imaging (DWI) sequence with increases in its signal-to-noise ratio.

Key Points: 
  • The most recently cleared Swoop® software improves the image quality of the diffusion-weighting imaging (DWI) sequence with increases in its signal-to-noise ratio.
  • An additional update in this software release increases the Swoop® Portable MR Imaging® System field of view by 10% for T1, T2, and FLAIR sequences to match the previously improved DWI sequence’s 20cm field of view.
  • The Swoop® system total installed base consists of commercial system installations (which make up total revenue), grant fulfillment installations, and research unit installations.
  • We view the total installed base as a key metric of the growth of our business and is measured from period over period.

Guardforce AI Announces Collaboration with Hong Kong Industrial Artificial Intelligence and Robotics Centre to Develop Worldwide Robotics Solutions and AI Cloud Platforms

Retrieved on: 
Thursday, June 30, 2022
Artificial intelligence, FLAIR, CEO, Research, Hong Kong Productivity Council, HKSAR, Government, GLOBE, Company, Ecosystem, U.S. Securities and Exchange Commission, Phrase, Robotics, Forward-looking statement, AIR, Security (finance), Technology, Robot as a service, Risk, Solution, NASDAQ, AI, Private Securities Litigation Reform Act, Safety, Hong Kong Science Park, Medical device, Tutoring, Limited, Flair

Guardforce AI and FLAIR plan to work together on providing customized robotics services to clients worldwide.

Key Points: 
  • Guardforce AI and FLAIR plan to work together on providing customized robotics services to clients worldwide.
  • Dr. Ming Ge, Chief Operating Officerof FLAIR, stated, Were very thankful to Guardforce AI for the sponsorship that will help accelerate our research work on AI and robotics development.
  • We look forward to collaborating with Guardforce AI on the successful application of our research results to enhance RaaS development and unleash innovative possibilities for industries seeking to adopt AI & robotics solutions.
  • Olivia Wang, CEO of Guardforce AI, stated, "Collaborating with FLAIR is an important milestone in establishing a first-class R&D center based in Hong Kong.

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

Retrieved on: 
Wednesday, February 16, 2022
Magnetic resonance imaging, Income, ERS, Weeneebayko Area Health Authority, Patient, ADC, Map, Picture archiving and communication system, PACS, DWI, Risk, MOOSE, ORS, Licensed practical nurse, Management, Weather, MRI, U.S. Securities and Exchange Commission, Transport, Security (finance), Private Securities Litigation Reform Act, Nasdaq, Health, Health Canada, Intensive care unit, Paola Lattus, Communications system, Technology, FDA, Deep learning, Queen's University, Partnership, Marketing, High-dependency unit, Growth, POC, Diagnosis, FLAIR, COVID-19, University, Medical imaging, GLOBE, Swoop, Hyperfine structure

Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON.

Key Points: 
  • Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON.
  • Queens University intends to utilize Swoop as part of a study to build evidence regarding the utility and affordability of a portable point of care (POC) MRI in a remote setting.
  • Queens University is situated on traditional Anishinaabe and Haudenosaunee territory and provides medical services to a predominantly Indigenous population in the Weeneebayko Area Health Authority (WAHA) in Northern Ontario.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Combinostics Demonstrates Latest cNeuro® Features and Applications at RSNA 2021

Retrieved on: 
Monday, November 29, 2021
Biotechnology, General Health, Medical Devices, Health, Radiology, Patient, ARIA, Amyloid, Non-functional testing, DICOM, RSNA, Technology, Biomarker, Brain, AI, Diagnosis, CMRI, DMDS, Neurodegeneration, Database, Hippocampus, Amyloid-related imaging abnormalities, Radiology, Research, AD, FLAIR, Artificial intelligence, MRI, PET, HIV disease progression rates, Caria, Lists of diseases, FDG, Medical device, Medical imaging

cNeuro 2.0 includes enhanced functionality and easily supports the addition of new applications.

Key Points: 
  • cNeuro 2.0 includes enhanced functionality and easily supports the addition of new applications.
  • The cNeuro suite of products currently includes the cMRI and cDSI applications.
  • Enhanced modularization introduced with cNeuro 2.0 facilitates the introduction of additional products to the cNeuro suite, such as the cARIA* and cPET* applications, which are both currently under development.
  • Combinostics AI-powered cNeuro suite of products helps clinicians make a difference in the lives of patients with neurological disorders.

Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics

Retrieved on: 
Monday, November 29, 2021
IPad, Risk, AI, CLASSA, Diagnosis, Nasdaq, Prospectus, Marketing, Artificial intelligence, Department, Private Securities Litigation Reform Act, Security (finance), Cayman Islands Directors Registration and Licensing Law, 2014, University, U.S. Securities and Exchange Commission, Illinois, Register, Registration statement, Failure, Sale, DL, Partnership, ICU, FLAIR, Business architecture, FDA, Person, Pathology, Growth, Securities Act of 1933, Liminal BioSciences, Patient, Paola Lattus, Magnetic resonance imaging, Technology, Deep learning, Income, SEC, Proxy, Business, COVID-19, MRI, Ownership, University of Illinois at Chicago, Name, High-dependency unit, Medical imaging

The result is Swoop, an easy-to-use, portable, and affordable system costing less than the annual service contract of many conventional MRI systems.

Key Points: 
  • The result is Swoop, an easy-to-use, portable, and affordable system costing less than the annual service contract of many conventional MRI systems.
  • With the launch of its deep learning-based advanced image reconstruction technology, Swoopcan deliver crisp, clear T1, T2, and FLAIR images.
  • In January, Hyperfine received FDA clearance for its advanced artificial intelligence (AI) application.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system.

Ohio State University Wexner Medical Center Receives Ohio's First Hyperfine Portable MRI Systems to Speed Scanning and Diagnosis for Urgent Brain Injuries

Retrieved on: 
Thursday, September 16, 2021
Ohio State University Wexner Medical Center, Income, Food, Stroke, Hyperfine structure, FDA, Technology, University, Surgical Innovation, Ohio State University, SITL, Yale New Haven Hospital, University of California, Irvine Medical Center, Doctor of Philosophy, Emergency department, Patient, Apple, MRI, Champaign County, Illinois, Emergency, Map, Brain, Food and Drug Administration, Physician, Solution, COVID-19, ADC, DWI, FLAIR, IPad, COVID, Magnetic resonance imaging, Hospital, Nursing, Parent, Medical imaging

The Ohio State Wexner Medical Center is the first in the state of Ohio, and one of the first in the country, to offer this technology to its patients.

Key Points: 
  • The Ohio State Wexner Medical Center is the first in the state of Ohio, and one of the first in the country, to offer this technology to its patients.
  • "As one of the leading comprehensive stroke centers in the country, Ohio State Wexner Medical Center has always been on the cutting edge of diagnosing and treating critical brain injuries," said Rob Korn, senior vice president of sales for Hyperfine.
  • "We're excited to provide Ohio State with the world's first portable MRI system which gives clinicians critical decision-making capabilities across a variety of clinical settings."
  • Hyperfine designed the Swoop Portable MR Imaging System to overcome patient transport and dedicated room requirements associated with fixed conventional MRI systems.